Functional and volumetric assessment of liver segments after portal vein embolization: Differences in hypertrophy response

被引:25
作者
Rassam, Fadi [1 ]
Olthof, Pim B. [1 ]
van Lienden, Krijn P. [2 ,3 ]
Bennink, Roel J. [2 ,3 ]
Besselink, Marc G. [1 ]
Busch, Olivier R. [1 ]
van Gulik, Thomas M. [1 ]
机构
[1] Univ Amsterdam, Dept Surg, Canc Ctr Amsterdam, Amsterdam UMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Canc Ctr Amsterdam, Amsterdam UMC, Dept Radiol, Amsterdam, Netherlands
[3] Univ Amsterdam, Canc Ctr Amsterdam, Amsterdam UMC, Dept Nucl Med, Amsterdam, Netherlands
关键词
STAGED HEPATECTOMY; HEPATOBILIARY SCINTIGRAPHY; PERIHILAR CHOLANGIOCARCINOMA; NEOADJUVANT CHEMOTHERAPY; MAJOR HEPATECTOMY; LIGATION; PARTITION; RESECTION; REGENERATION; RESECTABILITY;
D O I
10.1016/j.surg.2018.11.004
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Patients considered for liver resection with insufficient volume or function of the future remnant liver are candidates for portal vein embolization to allow safe resection. The aim of this study is to analyze the volumetric and functional responses after portal vein embolization and to evaluate predictors of the hypertrophy response. Methods: All patients who underwent portal vein embolization before liver resection 2006-2017 were included. Patients who did not undergo computed tomography-volumetry and functional assessment with technetium-99m mebrofenin hepatobiliary scintigraphy before and after portal vein embolization were excluded. The functional and volumetric response rates were calculated. Multiple regression analysis was conducted to examine the relationship between the hypertrophy response and potential predictors. Results: A total of 90 patients underwent portal vein embolization of the right liver. After 3 weeks, there was a significant increase in both volumetric and functional share of the future remnant liver (both P < .01). The increase in functional share exceeded the increase in volumetric share (P < .01). The median functional contribution of segment 4 after portal vein embolization was 41.5% (31.7%-48.7%) of the nonembolized lobe. Preoperative chemotherapy was not a significant predictor of the increase in function or volume. Compared with benign lesions, malignant diseases were significant negative predictors of the functional response. Conclusion: A total of 3 weeks after portal vein embolization, the functional response exceeded that of the volumetric response, meaning that the waiting time to resection potentially can be decreased. Segment 4 had a significant share of both volume and function, enabling surgical strategies only leaving segment 4 as a monosegment. Neoadjuvant chemotherapy had no negative influence on the hypertrophy response. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:686 / 695
页数:10
相关论文
共 30 条
[1]  
Bennink RJ, 2004, J NUCL MED, V45, P965
[2]   Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma [J].
Bruix, Jordi ;
Reig, Maria ;
Sherman, Morris .
GASTROENTEROLOGY, 2016, 150 (04) :835-853
[3]   Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection [J].
Cieslak, Kasia P. ;
Bennink, Roelof J. ;
de Graaf, Wilmar ;
van Lienden, Krijn P. ;
Besselink, Marc G. ;
Busch, Olivier R. C. ;
Gouma, Dirk J. ;
van Gulik, Thomas M. .
HPB, 2016, 18 (09) :773-780
[4]  
COUINAUD C, 1954, PRESSE MED, V62, P709
[5]   Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases [J].
Covey, Anne M. ;
Brown, Karen T. ;
Jarnagin, William R. ;
Brody, Lynn A. ;
Schwartz, Lawrence ;
Tuorto, Scott ;
Sofocleous, Constantinos T. ;
D'Angelica, Michael ;
Getrajdman, George I. ;
DeMatteo, Ronald ;
Kemeny, Nancy E. ;
Fong, Yuman .
ANNALS OF SURGERY, 2008, 247 (03) :451-455
[6]   Increase in future remnant liver function after preoperative portal vein embolization [J].
de Graaf, W. ;
van Lienden, K. P. ;
van den Esschert, J. W. ;
Bennink, R. J. ;
van Gulik, T. M. .
BRITISH JOURNAL OF SURGERY, 2011, 98 (06) :825-834
[7]   99mTc-Mebrofenin Hepatobiliary Scintigraphy with SPECT for the Assessment of Hepatic Function and Liver Functional Volume Before Partial Hepatectomy [J].
de Graaf, Wilmar ;
van Lienden, Krijn P. ;
van Gulik, Thomas M. ;
Bennink, Roelof J. .
JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (02) :229-236
[8]   The Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Approach Using Only Segments I and IV as Future Liver Remnant [J].
de Santibanes, Martin ;
Alvarez, Fernando A. ;
Santos, Fanny Rodriguez ;
Ardiles, Victoria ;
de Santibanes, Eduardo .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (02) :E5-E9
[9]   Liver uptake function measured by IODIDA clearance rate in liver transplant patients and healthy volunteers [J].
Ekman, M ;
Fjalling, M ;
Friman, S ;
Carlson, S ;
Volkmann, R .
NUCLEAR MEDICINE COMMUNICATIONS, 1996, 17 (03) :235-242
[10]   One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases [J].
Jaeck, D ;
Bachellier, P ;
Nakano, H ;
Oussoultzoglou, E ;
Weber, JC ;
Wolf, P ;
Greget, M .
AMERICAN JOURNAL OF SURGERY, 2003, 185 (03) :221-229